EGFR-TKIs resistance via EGFR-independent signaling pathways

Qian Liu1, Shengnan Yu1, Weiheng Zhao1

  • 1Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Molecular Cancer
|February 20, 2018
PubMed

Insights

Tyrosine kinase inhibitors (TKIs) benefit EGFR-mutated lung cancer patients but acquired resistance develops. Understanding resistance mechanisms like EGFR mutations and bypass signaling is key to developing new combination therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Tyrosine kinase inhibitors (TKIs) are effective for EGFR-mutated cancers, particularly lung cancer.
  • Acquired resistance limits the long-term efficacy of TKI treatments in most patients.
  • Resistance mechanisms include secondary EGFR mutations and activation of bypass signaling pathways.

Purpose of the Study:

  • To review the mechanisms of acquired resistance to EGFR-TKIs.
  • To discuss strategies for overcoming TKI resistance in cancer treatment.
  • To highlight the potential of combination therapies for improved clinical outcomes.

Main Methods:

  • Literature review of studies on TKI resistance in EGFR-mutated cancers.
  • Analysis of molecular mechanisms underlying acquired resistance.
  • Evaluation of ongoing and completed clinical trials for resistance-targeting agents.

Main Results:

  • Acquired resistance involves EGFR-dependent mechanisms (e.g., T790M mutation) and EGFR-independent mechanisms (e.g., RTK dysregulation, PI3K/Akt and MAPK pathway activation).
  • These mechanisms confer compensatory signaling, overriding EGFR inhibition.
  • Numerous clinical trials are investigating strategies to prevent or overcome TKI resistance.

Conclusions:

  • Combination therapies involving EGFR-TKIs and agents targeting resistance mechanisms offer a promising strategy.
  • This approach holds potential as a first-line treatment to improve patient outcomes in EGFR-mutated cancers.
  • Further research and clinical trials are essential to optimize these combination strategies.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.6K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K